Elicio Therapeutics ELTX
NASDAQ ELTX
$1.63 +0.02 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Elicio Therapeutics (ELTX) EBIT Margin (2020 - 2024)

Updated

Elicio Therapeutics (ELTX) recorded EBIT Margin of -1031.42% in FY2022, down 892.59 percentage points from -138.84% in FY2021.

Analysis

Elicio Therapeutics (ELTX) EBIT Margin (2020 - 2024) Analysis & Trends

  • Per Business Quant data, ELTX's EBIT Margin was -138.84% in FY2021 (+1780.37 pp) and -1919.20% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Elicio Therapeutics 45.57 Mn -42.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -6,827.33%
Dec 31, 2023 -12,522.67%
Sep 30, 2023 -4,378.46%
Jun 30, 2023 -19,941.03%
Jun 30, 2022 -954.36%
Mar 31, 2022 -878.94%
Dec 31, 2021 56.41%
Sep 30, 2021 -1,079.32%
Jun 30, 2021 -3,378.52%
Mar 31, 2021 -5,374.39%
Dec 31, 2020 -3,017.43%
Sep 30, 2020 -1,400.85%
Jun 30, 2020 -2,368.86%
Mar 31, 2020 -1,453.06%
API Access

Elicio Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ELTX&period=max&api_key=YOUR_API_KEY